Announcements Trials
Browse Landscape

Phase

Phase 2 11Phase 1 7Phase 1/2 4Phase NA 2Phase EARLY_PHASE1 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2

Interventions

Standard of Care 70Educational Status 60Interviews as Topic 54Methods 53Practice Guidelines as Topic 52Early Intervention, Educational 49Blood Specimen Collection 48Exercise 47Surveys and Questionnaires 44Magnetic Resonance Spectroscopy 40Specimen Handling 39Radiosurgery 28Palliative Care 22Radiotherapy 20Resistance Training 17Biopsy 17Patient Navigation 16Magnetic Resonance Imaging 15Diet Therapy 13Counseling 13Health Promotion 12Exercise Test 12Therapeutics 10Surgical Procedures, Operative 10Telemedicine 9Restraint, Physical 9Nutrition Assessment 9Genetic Testing 9X-Rays 8Radiation Dose Hypofractionation 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Immunotherapy, Adoptive × 90 days × Clear all
NCT07454226 2026-05-13

ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL

Institute of Hematology & Blood Diseases Hospital, China

Phase NA Recruiting
92 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07495631 2026-05-13

Pediatric-Inspired Regimen Combined With Venetoclax and Immunotherapy for Adult Ph-Negative Acute Lymphoblastic Leukemia

Institute of Hematology & Blood Diseases Hospital, China

Phase NA Recruiting
43 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡